TissueGene therapy gets Korean approval for OA

TissueGene Inc. (Rockville, Md.) said Korea approved regenerative therapy Invossa-K Inj. (TissueGene-C, TG-C) to treat osteoarthritis (OA) of the

Read the full 195 word article

How to gain access

Continue reading with a
two-week free trial.